Recent clinical data surrounding the medication Retatrutide , specifically the high-dose formulation ZPHC ZPHC, suggest a considerable effect on body mass loss and related health factors. Scientists anticipate that this innovative compound, influencing both GLP-1 and GIP pathways , may represent